BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 17315505)

  • 1. [Meningiomas].
    Kalamarides M; Goutagny S
    Rev Prat; 2006 Oct; 56(16):1792-8. PubMed ID: 17315505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature.
    Milker-Zabel S; Zabel-du Bois A; Huber P; Schlegel W; Debus J
    Strahlenther Onkol; 2006 Nov; 182(11):635-40. PubMed ID: 17072520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic radiosurgery and stereotactic radiotherapy in the treatment of skull base meningiomas.
    McGregor JM; Sarkar A
    Otolaryngol Clin North Am; 2009 Aug; 42(4):677-88. PubMed ID: 19751872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal meningioma: relationship between histological subtypes and surgical outcome?
    Schaller B
    J Neurooncol; 2005 Nov; 75(2):157-61. PubMed ID: 16132511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningiomas.
    Whittle IR; Smith C; Navoo P; Collie D
    Lancet; 2004 May; 363(9420):1535-43. PubMed ID: 15135603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiation treatment for benign meningiomas.
    Elia AE; Shih HA; Loeffler JS
    Neurosurg Focus; 2007; 23(4):E5. PubMed ID: 17961042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of radiosurgery during management of aggressive meningiomas.
    Harris AE; Lee JY; Omalu B; Flickinger JC; Kondziolka D; Lunsford LD
    Surg Neurol; 2003 Oct; 60(4):298-305; discussion 305. PubMed ID: 14505844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
    Adeberg S; Hartmann C; Welzel T; Rieken S; Habermehl D; von Deimling A; Debus J; Combs SE
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):859-64. PubMed ID: 22137023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of fractionated stereotactic radiotherapy for intracranial skull base benign meningiomas in single institution.
    Onodera S; Aoyama H; Katoh N; Taguchi H; Yasuda K; Yoshida D; Surtherland K; Suzuki R; Ishikawa M; Gerard B; Terasaka S; Shirato H
    Jpn J Clin Oncol; 2011 Apr; 41(4):462-8. PubMed ID: 21177777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign brain tumors. Meningiomas, pituitary tumors, and acoustic neuromas.
    Black PM
    Neurol Clin; 1995 Nov; 13(4):927-52. PubMed ID: 8584005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of radiation therapy in treating intracranial meningiomas.
    Rogers L; Mehta M
    Neurosurg Focus; 2007; 23(4):E4. PubMed ID: 17961041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification.
    Simon M; Boström J; Koch P; Schramm J
    J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):767-73. PubMed ID: 16306156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiation therapy for benign meningioma: long-term outcome in 318 patients.
    Fokas E; Henzel M; Surber G; Hamm K; Engenhart-Cabillic R
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):569-75. PubMed ID: 24751409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria.
    Pearson BE; Markert JM; Fisher WS; Guthrie BL; Fiveash JB; Palmer CA; Riley K
    Neurosurg Focus; 2008; 24(5):E3. PubMed ID: 18447742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution.
    Rosenberg LA; Prayson RA; Lee J; Reddy C; Chao ST; Barnett GH; Vogelbaum MA; Suh JH
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):427-32. PubMed ID: 19427553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
    Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
    Mason WP; Gentili F; Macdonald DR; Hariharan S; Cruz CR; Abrey LE
    J Neurosurg; 2002 Aug; 97(2):341-6. PubMed ID: 12186462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic radiosurgery of meningiomas.
    Kondziolka D; Lunsford LD; Coffey RJ; Flickinger JC
    J Neurosurg; 1991 Apr; 74(4):552-9. PubMed ID: 2002367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.